Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection

Infection and Immunity

Volumn 65, Issue 2, 1997, Pages 373-379

  Garvy, Beth A ^a   Ezekowitz, R Alan B ^b   Harmsen, Allen G ^a  

^a TRUDEAU INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EOSINOPHILIA; GIANT CELL; HOST RESISTANCE; IMMUNE RESPONSE; INFLAMMATION; INTERSTITIAL PNEUMONIA; MOUSE; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PRIORITY JOURNAL; SCID MOUSE; SPLEEN CELL;

EID: 0031025286     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.2.373-379.1997     Document Type: Article

References (22)

1. Beck, J. M., H. D. Liggitt, E. N. Brunette, H. J. Fuchs, J. E. Shellito, and R. J. Debs. 1991. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect. Immun. 59:3859-3862.
2. Chen, W., E. A. Havell, and A. G. Harmsen. 1992. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect. Immun. 60:1279-1284.
3. Chen, W., J. W. Mills, and A. G. Harmsen. 1992. Development and resolution of Pneumocystis carinii pneumonia in severe combined immunodeficient mice: a morphological study of host inflammatory responses. Int. J. Exp. Pathol. 73:709-720.
4. Corry, D. B., H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, and R. M. Locksley. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperrcactivity. J. Exp. Med. 183:109-117.
5. Coyle, A. J., S. Tsuyuki, C. Bertrand, S. Huang, M. Aguet, S. S. Alkan, and G. P. Anderson. 1996. Mice lacking the IFN-γ receptor have an impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile. J. Immunol. 156:2680-2685.
6. Cushion, M. T., J. J. Ruffolo, and P. D. Walzer. 1988. Analysis of the developmental stages of Pneumocystis carinii in vitro. Lab. Invest. 58:324-331.
7. Dunn, P., and R. North. 1991. The importance of route of infection in determining the extent of exacerbation of listeriosis by anti-interferon-γ monoclonal antibody. J. Interferon Res. 11:291-295.
8. Harmsen, A. G. 1988. Role of alveolar macrophages in lipopolysaccharide-induced neutrophil accumulation. Infect. Immun. 56:1858-1863.
9. + cells in resistance to Pneumocystis carinii pneumonia in mice. J. Exp. Med. 172:937-945.
10. Harmsen, A. G., W. Chen, and F. Gigliotti. 1995. Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice. Infect. Immun. 63:2391-2395.
11. Havell, E. A. 1986. Purification and further characterization of an antimurine interferon-γ monoclonal neutralizing antibody. J. Interferon Res. 6:489-497.
12. Ishimine, T., K. Kawakami, A. Nakamoto, and A. Saito. 1995. Analysis of cellular response and gamma interferon synthesis in bronchoalveolar lavage fluid and lung homogenate of mice infected with Pneumocystis carinii. Microbiol. Immunol. 39:49-58.
13. + T cells. J. Immunol. 144:3288-3295.
14. Mosmann, T. R., and S. Subash. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138-146.
15. Pesanti, E. L. 1991. Interaction of cytokines and alveolar cells with Pneumocystis carinii in vitro. J. Infect. Dis. 163:611-616.
16. + T cells into severe combined immunodeficiency mice. J. Clin. Invest. 90:673-678.
17. Shear, H. L., G. Valladares, and M. A. Narachi. 1990. Enhanced treatment of Pneumocystis carinii pneumonia in rats with interferon-γ and reduced doses of trimethoprim/sulfamethoxazole. J. Acquired Immune Defic. Syndr. 3:943-948.
18. Suzuki, Y., M. A. Orellana, R. D. Schreiber, and J. S. Remington. 1988. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240:516-518.
19. Swain, S. L. 1994. Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity 1:543-552.
20. Wiley, J. A., and A. G. Harmsen. 1995. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J. Immunol. 155:3525-3529.
21. Williams, D. M., G. I. Byrne, B. Grubbs, T. J. Marshal, and J. Schachter. 1988. Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice. Infect. Immun. 56:3004-3006.
22. Wilson, R. A., P. S. Coulson, C. Betts, M.-A. Dowling, and L. E. Smythies. 1996. Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-γ receptor gene exposed to the irradiated Schistosoma mansoni vaccine. Immunology 87:275-282.